Cargando…

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469942/ https://www.ncbi.nlm.nih.gov/pubmed/36110508 http://dx.doi.org/10.2147/JIR.S387402

Ejemplares similares

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer
por: Wang, Nan, et al.
Publicado: (2022)

Development and Validation of a Prognostic Classifier Based on Lipid Metabolism–Related Genes in Gastric Cancer
por: Wei, Xiao-Li, et al.
Publicado: (2021)

Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]
Publicado: (2023)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]
por: Casadei-Gardini, A, et al.
Publicado: (2019)

Corrigendum to “Expression and Gene Regulation Network of Metabolic Enzyme Phosphoglycerate Mutase Enzyme 1 in Breast Cancer Based on Data Mining”
por: Wang, Yongxuan, et al.
Publicado: (2021)

Corrigendum to “Metabolic Syndrome, Inflammation, and Cancer”
por: Wu, Yong, et al.
Publicado: (2017)

Corrigendum to “Dietary Lipids in Health and Disease”
por: Amin, Kamal A., et al.
Publicado: (2020)

Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer [Corrigendum]
Publicado: (2021)

Corrigendum to Efficacy of Tiaoqiheying decoction in the treatment of spasmodic pain and lipid metabolism after acute ischemic stroke
Publicado: (2020)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

Corrigendum to: Differences in gene-expression profiles in breast cancer between African and European-ancestry women
por: Ping, Jie, et al.
Publicado: (2020)

Corrigendum to: Heterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India
por: Sharma-Oates, Archana, et al.
Publicado: (2018)

Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Publicado: (2019)

Corrigendum to The Effect of Acupuncture in Breast Cancer–Related Lymphoedema (BCRL): A Systematic Review and Meta-Analysis
Publicado: (2019)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women [Corrigendum]
Publicado: (2021)

Corrigendum to: Modification of ERα by UFM1 Increases Its Stability and Transactivity for Breast Cancer Development
por: Yoo, Hee Min, et al.
Publicado: (2023)

Corrigendum to “Recent Advances in Microwave Imaging for Breast Cancer Detection”
por: Kwon, Sollip, et al.
Publicado: (2018)

Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer
por: Al-Ejeh, F, et al.
Publicado: (2014)

Corrigendum: Affiliation Correction. Development and Validation of a Risk Scoring System Derived from Meta-Analyses for Papillary Thyroid Cancer
por: Suh, Sunghwan, et al.
Publicado: (2023)

Corrigendum to “Prognostic Role of Neutrophil to Lymphocyte Ratio in Ovarian Cancer: A Meta-Analysis”
Publicado: (2020)

Validation of second trimester miscarriages and spontaneous deliveries [Corrigendum]
Publicado: (2017)

Corrigendum to ‘ABHD15 regulates adipose tissue lipolysis and hepatic lipid accumulation’ [Molecular Metabolism 25 (2019) p.83–94]
por: Stöckli, Jacqueline, et al.
Publicado: (2021)

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Publicado: (2015)

Validation of the Chinese Version of the Shame and Stigma Scale in Patients with Head and Neck Cancer [Corrigendum]
Publicado: (2020)

Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

Corrigendum to “Claudin-1 Is a Valuable Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis”
por: Zuo, Didi, et al.
Publicado: (2020)

Corrigendum to “The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients after Radical Surgery”
por: Zheng, Kuo, et al.
Publicado: (2020)

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021)

Corrigendum to “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”
por: Zhao, Jing, et al.
Publicado: (2019)

Intraoperative Prediction of Non-Sentinel Lymph Node Metastasis Based on the Molecular Assay in Breast Cancer Patients [Corrigendum]
Publicado: (2020)

Corrigendum to “Prospective Analysis of Lipid Variations in Hyperthyroid Subjects from Lahore, Pakistan”
por: Iqbal, Muhammad Amir, et al.
Publicado: (2022)

Corrigendum: High-throughput, nonperturbing quantification of lipid droplets with digital holographic microscopy
por: Campos, Vasco, et al.
Publicado: (2022)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Publicado: (2015)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
Publicado: (2018)

The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy [Corrigendum]
Publicado: (2019)

Corrigendum to “Expression of Intratumoral IGF-II Is Regulated by the Gene Imprinting Status in Triple Negative Breast Cancer from Vietnamese Patients”
por: Radhakrishnan, Vinodh Kumar, et al.
Publicado: (2018)

Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum]
Publicado: (2019)

Corrigendum to “High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer”
por: Yang, Long, et al.
Publicado: (2019)

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”
por: Wang, TingAn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ais4ogeqieg355ftcu6fn4fpnl